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Abstract
Background: Dysphagia and other eating and drinking difficulties are common in progressive neurological diseases.
Mealtimes can become a major source of difficulty and anxiety for patients and their families. Decisions about eating,
drinking and care can become challenging as disease progresses, and the person in question loses the capacity to
participate in decisions about their own care. We sought to investigate how patients and their family members make
decisions about their future care as their condition deteriorates, with a particular focus on mealtimes, eating and
drinking.
Methods: Longitudinal qualitative in-depth interviews were undertaken with patients and their family members (N = 29)
across a range of disease groups, including: dementia, Parkinson’s Disease, Huntington’s Disease, Progressive Supranuclear
Palsy, Motor Neurone Disease, Multiple Sclerosis. Patients had varying degrees of eating and drinking difficulties, and
levels of decision-making capacity. Interviews were ‘participant led’ and undertaken in the patients’ own homes or a place
of their choosing. Follow-up interviews were three months to one year later depending upon disease trajectory.
Interviews were audio recorded and analysed in NVivo using a Thematic Analysis approach.
Results: Twenty-nine participants were interviewed between 2015 and 2017. Two key themes emerged from the
analysis: 1) Health Literacy: the extent to which patients and relatives appeared to know about the condition and its
treatment. Patients and their family members varied in their ability to speak and communicate about their condition and
prognosis. 2) Planning style: the extent to which participants appeared to value involvement in advance care-planning.
Patients and their family members varied in the way in which they made decisions: some preferred to ‘take each day as it
comes’, while others wished to plan extensively for the future.
Conclusions: Issues with eating and drinking are often overlooked. Clinicians need to understand both the patient’s level
of health literacy and their style of planning before communicating with patients and their families about these sensitive
issues.
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disease, Progressive Supranuclear palsy, Motor Neurone disease, Multiple sclerosis
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Background
Mealtimes are usually an important part of everyday life,
with opportunities for pleasure and socialising [1, 2]. Social
meanings attached to mealtimes are connected to deep
experiences of self, childhood, care and identity [2–4].
People with progressive neurological diseases experience
complex and unpredictable changes in their physical, cogni-
tive, emotional and behavioural functions which can affect
their decision-making capacity and their abilities at meal-
times, including changes in swallowing ability. These vary
between individuals and across disease groups [5–11].
Estimates of the prevalence of dysphagia range from:
13–57% in dementia [12]; 32–85% in Parkinson’s Disease
(PD) [13]; 37% in Huntington’s Disease (HD) [14]; 30–
100% in Motor Neurone Disease (MND) [15]; 34–81%
in Multiple Sclerosis (MS) [16, 17]; and 16–80% in Pro-
gressive Supranuclear Palsy (PSP) [18–20]. Difficulties
with eating and drinking may arise from: physical im-
pairments (impaired neuromuscular coordination of
swallowing, tremor, rigidity, impaired coordination); cog-
nitive difficulties (not recognising food, forgetting to
chew or swallow, forgetting mealtimes); and behavioural
difficulties (refusing to chew or swallow, spitting out
food, or mealtime aggression) [21–23]. These can cause
weight-loss, malnutrition, dehydration and aspiration
pneumonia [24]. Mealtimes can become a major source
of difficulty and anxiety for patients and their families
[25], with emotional distress from loss of selfhood, social
isolation and fear of becoming a burden to others [26].
Pharmacological and non-drug interventions aim to im-
prove patients’ quality of life through disease management
and symptom control [27–30]. Support and interventions
to address swallowing difficulties include; sitting with the
individual at mealtimes, spooning food into the mouth,
thickened food and drinks, nutritional supplements, and
tube feeding by percutaneous endoscopic gastrostomy
(PEG) or nasogastric (NG) tube [31, 32].
Tailoring these interventions to best suit the individual
needs and wishes of each patient is an important part of
the care-planning process. However, as illness pro-
gresses, decision-making capacity and communication
ability may become impaired or lost, making shared
decision-making more challenging. Early decisions are
needed for some conditions, such as MND, as progres-
sion may be rapid with a short survival time and poten-
tial loss of decision-making capacity [10, 30]. For other
conditions, such as dementia, PD and MS, the disease
trajectory is typically longer, though unpredictable and
uncertain, potentially allowing more time to make deci-
sions [7, 8, 28]. If asked to make decisions in advance,
patients are considering an uncertain and unknown fu-
ture that may be difficult to contemplate at a time when
they are adjusting to living with and coping with pro-
gressive and life-limiting illness.
Aims
We therefore undertook a study of patients and their
families with a range of progressive neurological dis-
eases. We investigated their experiences and views on
decision-making concerning their care as their disease
progressed, with a focus on problems with eating and
drinking. The key research question was:
How do patients and their family members make deci-
sions about their future care, with a particular focus on
mealtimes, eating and drinking?
Methods
Design and recruitment
Longitudinal qualitative interviews were used to collect
data from people with progressive neurological disease,
their carers and healthcare professionals. A purposive
sampling strategy was used to recruit a maximum variety
sample of participants by disease group, decision-making
capacity and degrees of eating and drinking difficulties.
Patient ‘clusters’ were recruited comprising up to four
participants: the patient (if they had the decision-making
capacity to consent to participate); a friend or relative (“in-
formal carer”); a healthcare professional; and a paid carer
(if they had one). In the first instance, (Time one - T1)
in-depth qualitative interviews lasting 20 to 90 min were
conducted with each participant. The length of the inter-
view was determined by each participant’s health and their
responses to the questions. At a second optional ‘meal-
time interview’ approximately one week later; the patient,
relative and interviewer shared a meal in the participant’s
home. Subsequent follow-up interviews (Time two - T2),
were undertaken three to twelve months later depending
upon the trajectory of the disease.
Clinical collaborators initially approached potential pa-
tient participants with a study pack containing: a cover
letter, an information sheet, a reply slip and a ‘freepost’
return envelope. Upon receipt of a reply slip, a member
of the study team arranged a meeting at which the study
was further explained, decision-making capacity was
assessed, and if the participant chose to participate,
informed consent was obtained. Patient participants
were invited to nominate a relative or friend, a
healthcare professional and a paid carer, who were all
approached to participate.
Ethical issues
Capacity to consent to participation was assessed before
each interview by the interviewer, who had received
training in assessing decision-making capacity. Partici-
pants with capacity gave written consent, or verbal
audio-recorded consent if they had communication or
physical difficulties. If capacity was in doubt, a consultee
was asked to provide written informed assent in accord-
ance with the Mental Capacity Act 2005.
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To minimise the potential for distress during discussion
of possible future feeding difficulties, clinical collaborators
only approached patients they judged suitable for such
discussion and raised the research topic at that time. Fur-
ther details were included in the participant information
sheet. The interview schedule was participant-led; al-
though the interviewer raised eating and drinking and
deterioration in the condition in broad terms; these topics
were only discussed in more detail if raised by partici-
pants. For example, PEG was only discussed if participants
had already mentioned tube feeding. Participants were
given contact details for support, including their GP,
district nurse, specialist nurse, consultant and
condition-relevant support groups or networks. None
requested that the researcher contact these on their
behalf. Ethical approval was given by the London
South East Research Ethics Committee (REC refer-
ence: 14/LO/1156, IRAS project ID: 156054).
Research sample
Forty-two participants were interviewed between one to
three times each between January 2015 and April 2017.
This paper focuses on the findings from the interviews
with patients and their relatives (N = 29). Disease groups
represented were Parkinson’s Disease (PD), Huntington’s
Disease (HD), Motor Neurone Disease (MND), Progres-
sive Supranuclear Palsy (PSP), Corticobasal Degener-
ation (CBD), Multiple Sclerosis (MS) and dementia
(including both Alzheimer’s Disease and Frontotemporal
Dementia). (Table 1) Gender identifiers have been re-
moved from the text for reasons of confidentiality.
Data analysis
The interviews were audio-recorded, transcribed,
anonymised and entered into NVivo 11 for analysis.
Thematic analysis was used for data analysis and in-
terpretation [33]. Coding was undertaken by GC, SaB
and JT. Initial open inductive data driven coding was
refined into broader themes that were further
reviewed, refined and discussed between the coders to
develop higher level analytical themes. Themes were
refined on the basis of salience of content, as well as
frequency of appearance.
Results
Themes relating to the research question (‘what matters
to patients and their carers when planning for the future,
with a focus on eating and drinking?’) emerged in two
groups: those relating to the extent to which patients
and carers appeared to know about the condition and its
treatment (health literacy), and those relating to the
extent to which they appeared to value involvement in
advance care-planning (planning style). These are
presented in more detail below, with illustrative excerpts
from the dataset.
Theme one: Health literacy
Most participants characterised themselves as suffi-
ciently informed about what may lie ahead for them:
I: Are there any issues that you would like, or would
have liked, more information on?
P: No, because at the time they told us there was
nothing. So they were quite up front about that, weren’t
they [laughs] and so everything plus has been a bonus
ever since, hasn’t it? [Carer of HD patient. R622].
P: No, I think everyone’s been honest. Yes, even in
terms of the timeframes you’ve got, I think everyone
has been very honest, yes [MS patient. P412]
However, this satisfaction was not universal. Some
wanted more information on their condition and its
likely progression, or about options for managing eating
difficulties, particularly information about percutaneous
endoscopic gastrostomy (PEG):
P: If we’d have had more information then, we would
have been more prepared for things as time goes on
[Carer of PD patient. R223].
P: They could do a bit more to be progressive in
trying to explain to people what they’re about to
experience. It’s quite shocking if you, you know,
you’re looking at it for the first time [Carer of
MND patient. R322].
P: Well I think I would have probably gone for the
PEG earlier, if I’d have known. Obviously when the
PEG was going in I weren’t that sure because I didn’t
really know about it then, but actually having it done
has made my job a lot easier. I mean, it was difficult
feeding him/her before that, you know [Carer of HD
patient. R622].
Participants’ ability to speak about their condition and
potential future progression varied by disease group. Know-
ledge of prognosis appeared greatest in the HD, MND and
PSP/CBD groups, with those in the Dementia and PD
groups seemingly less able to articulate what lay in store.
Experts by experience
The HD group felt they had good knowledge of the con-
dition because they had seen how it affected family
members. They characterised this experience, rather
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than anything they had been told by healthcare profes-
sionals, as the source of their health literacy:
I: And at that point did they explain to you how the
illness would progress?
P: Well I already knew that from his/her mother and
his/her aunties and uncles and it was, you know,
family members really.
I: So they didn’t need to explain anything...
P: Not really, no.
I: Did they talk about issues with eating and drinking
or is that something that you...?
P: Well no, because you didn’t really see that bit, you
know, you didn’t really see that part of the relatives, you
Table 1 Cross-tabulation of participants, disease groups and decision-making capacity (N = 29 participants consented)
Cluster
code
Primary
participant
disease group
Primary participant
decision-making
capacitya
Primary participant
age group in years
Years
since
diagnosis
Nominated
relative or
friend
Total no. of patients
and relatives within
cluster
No. of participants
consented for
interviewb
A Frontotemporal
Dementia
Partial 65–80 6 Wife 2 2
B Alzheimer’s
Disease
No 65–80 3 Friend 2 1
C Parkinson’s
Disease
Yes 65–80 2 Partner 2 2
D Parkinson’s
Disease
Yes 65–80 1 Daughter 2 2
E Multiple
Sclerosis
Yes 40–64 19 N/A 1 1
F Multiple
Sclerosis
Yes 40–64 8 Husband 2 2
G Motor Neurone
Disease
Yes 65–80 < 1 Wife 2 2
H Motor Neurone
Disease
No 65–80 2 Husband 2 1
I Motor Neurone
Disease
Yes 40–64 2 N/A 1 1
J Progressive
Supranuclear
Palsy
Yes 65–80 5 [Relative
relationship
redacted]
2 2
K Huntington’s
Disease
No 65–80 3 Husband 2 1
L Huntington’s
Disease
Yes 40–64 15 Husband 2 2
M Multiple
Sclerosis
No 65–80 23 Wife 2 1
N Progressive
Supranuclear
Palsy
Partial 65–80 1 Husband 2 2
0 Motor Neurone
Disease
Yes 65–80 < 1 Wife 2 2
P Progressive
Supranuclear
Palsy
Yes 40–65 3 Husband 2 2
Q Alzheimer’s
Disease
No 65–80 12 Wife 2 1
R Parkinson’s
Disease
Yes 65–80 6 Husband 2 2
Totals 34 29
aDecision-making capacity assessed at time of interview by the interviewer in relation to the capacity to participate in a qualitative interview
bWhere the primary participant (patient participant) had partial or variable decision-making capacity, assent for interview participation was taken from a consultee
by the interviewer. Where the primary participant did not have the capacity to participate in an interview, interviews were not undertaken with them
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used to go and visit them but you didn’t really consider
that and his/her aunty didn’t want a PEG, s/he
stipulated that s/he didn’t want a PEG and obviously s/
he had swallowing problems and died.
I: Yeah. So his/her aunty knew early on but s/he just
didn’t want...?
P: Yeah, s/he didn’t want nothing like that, no, s/he
didn’t want to be messed about [Carer of HD patient.
R622].
I: So, at the time s/he was first diagnosed, did anyone
talk to you about how the condition would progress?
P: We were quite aware of that … no, we haven’t really
been told by anyone [Carer of HD patient. R621].
Well informed from the outset
Participants in the MND and PSP/CBD groups spoke con-
fidently and fluently about prognosis, often using medical
vocabulary. They identified the information provided by
health professionals as the source of their health literacy:
I: …and did they speak to you about how the
condition would progress?
P: Yeah. I mean that’s obviously part of the condition
and that was always one of the things that
[Consultant] and [Consultant 2] talked about in terms
of the ability to swallow through the deterioration with
the muscles. That was one of their biggest concerns
about, obviously which would cause aspirational
pneumonia, so they were very adamant about, you
know, making sure that we did everything possible to
ensure that we didn’t cause that. And they spoke
obviously about the PEG and, you know, the benefits of
the PEG [Carer of CBD patient. R523].
I: So when you saw the doctors at [Clinic] did they
outline for you how the disease would progress?
P: Yeah. Yeah, I mean you get the kind of assessment
that you would expect from a Consultant, and of
course they have a Care Team there which you may be
familiar with, so the moment they begin to think about
something as serious as Motor Neurone, or whatever
else it is, the Care Team are involved and they of
course, they’re made up of a dietician, a speech
therapist … there’s three of them, and you know, they
go through the whole business in great detail. So, you
know, you can’t fail to understand what’s going on and
the support was very good at [Hospital] seen very
regularly [Carer of MND patient. R322].
I: At that time, were you told about the progression of
his/her condition?
P: Yeah, yeah, straight away he told us how, how it
does progress but this seems to be progressing in a lot
of ways different to the other people we see at the
meetings, yeah? S/he still walks, most of the people we
know are in wheelchairs and that, and s/he gets on
quite well [Carer of PSP patient. R521].
However, being ‘well informed’ by clinicians did not
predict the participants’ choices. For example, within the
group of four participants diagnosed with MND, all four
had discussed PEG with their care team but: one chose
PEG feeding; one was strongly considering PEG feeding
but died unexpectedly during the course of the study,
and two were early stage and undecided.
Mixed picture
In MS clusters, responses were more mixed. Some, much
like the MND and PSP/CBD groups, appeared to have
been kept fully informed by healthcare professionals:
I: At that point, did they explain to you how the
disease would progress?
P: Yes, it was, progressing was quite rapidly, and, but
they did explain the care needs for the future, and
what would be needed. Yes, yes, they did explain it
quite harshly, and that’s what I want, you know, they
did explain it fully [MS patient. P412].
Others reported receiving little information from
healthcare professionals, but were able to use other
sources to develop their health literacy:
I: So who first told you that you may or may not get,
swallowing disorders in the first place?
P: Well, it’s part of the progression of the disease.
I: And when did they first raise that with you? Was
that at the time of your diagnosis or was that later on?
P: Nothing was given to me at the time of
diagnosis, it’s all been picked up as it’s gone along.
Various online chat rooms about MS, talking to
other people with MS, common sense on these
things and also I always have to treat my MS as
something I’m going to look forward in the future
dealing with, rather than leaving it, how you deal
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with it on a catch-up basis so it’s best to be in-
formed [MS patient. P411].
However, others in the MS group described an appar-
ent choice to remain uninformed, although information
was available:
I: And at that point did any healthcare
professionals talk to you about how the disease
would progress?
P: The information was there, [Patient] chose not to
want to know really, s/he... I think it took her/him ten
years to take it in, and that was her/him. I obviously
looked up what was going to happen and had much
more of an idea but s/he chose to not know [Carer of
MS patient. R423].
Still unaware
In contrast, participants in the dementia and PD clusters
were less able to articulate their prognosis, rarely used
technical language, and were sometimes hesitant in
speaking. Unlike those in the MS group, who described
choosing not to find out what lay in store; these partici-
pants appeared to have been offered less information
than those in the other groups:
I: And Dr [Consultant] has explained how the
condition will evolve in the future?
P: Um, not really, I haven’t really asked. At least I
did ask, you know, I know that s/he’s on the lower
scale of dementia, sort of, you know, not up here
but down here. I’ve no idea, I think it’s different
for... I don’t think they can say. I think that’s why I
haven’t been told, they can’t really say … Because,
you know, I’m not sure if s/he will lose his mobility
or if s/he will become rigid or shaky or you know,
like Parkinson’s or something like that, I don’t know
[Carer of dementia patient. R121].
I: So when you were there [Clinic], did they talk about
how the dementia would progress? Or the eating and
drinking would either?
P: No. Nothing [Lay carer dementia patient. R122].
I: So has he talked to you about how the condition will
progress in the future? Has the doctor explained……?
P: No. As far as he is concerned he doesn’t have an
appointment with me for another six months [PD
patient. P211].
I: And when they told you about that, did they tell you
how about it might develop in the future?
P: No, not, it might not, it might just stay like it, so
you know, I just carry on, and luckily it’s me left hand,
me left arm, so I’m right-handed so it doesn’t affect
me, it doesn’t keep me awake at night or nothing [PD
patient. P212].
Theme two: Planning style
The extent to which participants expressed a wish to be
involved in advance care-planning varied within and be-
tween the condition groups. Two main themes emerged:
those who wanted to plan ahead and make their own de-
cisions about care and treatment in advance, and those
who preferred to live in the present, deferring decisions
about future care. Some participants described using a
mixture of those two approaches (with some switching
preference as the condition progressed). For a small
group of participants, the concept of care planning held
little meaning as they did not perceive that there were
any decisions to make.
‘Advance planning’
Advance planning was used by some participants as a
way of extending the zone of personal autonomy and in-
volvement in decision-making beyond the stage when
their ability to make decisions or communicate their
wishes would be lost:
P: In the early days of the diagnosis we obviously
discussed his/her thoughts, his/her wishes going
forward, s/he made her end of life wishes well known,
they’re documented. I think I understand everything
that [Name] wants and I totally agree with some of
the things that s/he wants but yes, we have discussed
that [Carer of CBD patient. R523].
This group described a need for information about the
kinds of interventions to support nutritional intake that
might be considered as the condition progressed:
P: We needed it [information on PEG] as far as I’m
concerned, I mean it’s all bad news….you can mope
around but there is the practical side to the whole
business, even if it’s your wife or husband, you need to
know what, what’s about to happen and what can be
done [Carer of MND patient. R322].
Some participants expressed a desire to be more en-
gaged in the planning of care and were frustrated by the
lack of information on offer:
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P: That’s where it becomes quite frustrating ‘cos I’m
doing my utmost to do the best for the wife, naturally,
and there doesn’t seem to be that outside help to guide
you and put you on a little bit further and with a bit
more help [Carer of PD patient. R223].
However, the relationship between adoption of an ‘ad-
vance planning’ strategy and the need and desire for in-
formation was not straightforward. Some participants
acknowledged a need for information but nonetheless
did not want to be told everything:
P: We got information mainly at [Hospital] but it was
very sort of top level and; ‘Here’s some information but
we don’t have to talk about it yet, you know, we’ll talk
about it when you’re ready and unless we have to talk
about it before’. So it was handed to me, for me to
decide when I wanted to talk about it….. I think we
needed to know what lay ahead, but only at top level,
and not to go into too much detail about anything
that didn’t have an immediate or a near impact on
me, certainly in the earlier days when you’re taking
everything on board [MND patient. P313].
Furthermore, information from health professionals
did not always seem to be an important factor in the ad-
vance planning process. Some participants made all their
own care decisions in advance, in keeping with their per-
sonality and based on long-term values:
P: I mean that’s the way [Name] was, it may not be
everybody’s way of doing things, but you know, as I
said to you, s/he was very independent and s/he made
his/her own decisions … so you know, s/he’s not the
sort of person that’s going to, s/he’s going to rely on
specialists to help him/her but s/he will be making his/
her own decisions [Carer of MND patient. R322].
These decisions were not always consistent with the
advice and information offered by healthcare profes-
sionals. One participant planned to seek assisted suicide.
Despite receiving information about options to alleviate
their concerns about a distressing death, they chose to
end their own life before the condition’s natural
conclusion:
I: So is there something particular that you’re
frightened of in the progression, that makes you think
you would like to end your life sooner? Or is there
another reason you decided that you wanted to make
the visit to Dignitas?
P: I don’t know because I spoke to [Consultant] last
time about it. I was frightened of drowning in my own
secretions, of choking to death. And he said it wasn’t
like that, people usually slip away but, so, but I’m
quite pragmatic about it because of this condition isn’t
going to get any better. So I can’t see why prolonging it.
[Patient identity withheld for reasons of confidentiality].
For this participant, reassurance that the dysphagia
that they feared most would not arise did not have
any impact upon the decision to seek assisted sui-
cide. The provision of additional information to cor-
rect a possible misunderstanding did not change the
decision. The inference that the decision was actually
grounded in deep-seated values, rather than anxiety
based on a potentially mistaken belief about the way
the condition would progress, was expressed by their
relative:
P: S/he’s very practical, s/he’ll see it as the best thing
all round for everybody, including her/himself; s/he
said ‘I’m fed up with being like this’. S/he’s always sort
of had her/his independence, s/he’s always worked, you
know, had a good job [Carer of patient who chose
assisted dying; identity withheld for reasons of
confidentiality].
‘Take each day as it comes’
Some participants were hesitant to engage with, or
discuss, decisions concerning their future care. Par-
ticularly in the early stages of illness they preferred to
focus on the ‘here and now’, rather than thinking
about problems that might lie ahead. Decisions about
future care were deferred to a later date, sometimes
in the apparent hope that the eventualities that they
could plan for may never arise:
I: Did they discuss about how it [PD] might develop in
the future?
P: No, not, it might not, it might just stay like it, so
you know, I just carry on [PD patient. P212].
P: So, I mean, that’s going to be an ongoing problem
now I suppose? Unless something happens in... I don’t
know. I don’t know if that happens in the brain, that
things stop functioning and they start up again? [Carer
of Dementia patient. R121].
Some participants appeared to be aware of their prog-
nosis, and of their developing problems with eating and
drinking, but preferred not to focus on them. Sometimes
this coping strategy was characterised as an active
decision:
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P: I work out how to cope with it; don’t go thinking too
much in the future. But of course we all have people
like Stephen Hawking in our minds, and think, ‘is that
where we’re going to end up, looking like him?’…. ‘And
if that’s what people visualise us as, where we’re going
to end up, it’s a bit of a daunting prospect’ [MND
patient. P314].
Others discussed their swallowing difficulties in a way
that suggested they were aware of the problem but, per-
haps unconsciously minimising or attempting to ignore it:
P: When I’m very tired I have to be more careful
about my swallowing, and make sure that I chew my
food thoroughly, but at the moment it doesn’t really
affect me greatly … I do have episodes of choking when
I’m drinking but other than that, no, it’s not a problem
[MS patient. P411].
Finally, some participants characterised their reluc-
tance to be involved in future care planning as normal
or expected for people of an older generation:
I: So…. a will, but no plans about his/her care?
P: No, s/he said s/he knew I’d look after him/her, so I
just left it at that. I don’t think people of that age like
to talk about that, you know, it wasn’t done then, was
it? It just happened [Carer of Dementia patient.
R122].
For participants who did not wish to engage in plan-
ning for the future, information about prognosis was not
always welcome. Some wished that the information
about diagnosis and prognosis had never been given:
P: I would have rather they hadn’t told [patient] he had
MND … If nobody told s/he’d got MND because s/he’d
have just carried on thinking well, I’m getting old, I’ve
got rheumatism, I can’t lift my arm, I can’t do this,
can’t do that and s/he wouldn’t be stressed out and
upset like s/he is, so [Carer of MND patient. R321].
However, the relationship between this strategy and satis-
faction with the amount of information provided was not
straightforward. For some, it was information about prog-
nosis that prompted them to choose this strategy:
I: Did they talk to you then about how the illness
would develop, or did they just sort of…….?
P: Well they did, a little bit, but in those days with
Alzheimer’s Society, you know they don’t do it the same
nowadays, there was a lovely lady … and she just said
to me, she says [Name], “I’m going to be brutal”, and
I said “Right, go on”, she said “[Patient]‘s fine now”, she
says “Enjoy your time that you’ve got with him/her
now because it will get worse and worse and worse”
[Carer of Dementia patient. R123].
For others, awareness of the complex and uncertain
future lay behind their reluctance to engage in advance
care planning. They expressed a preference for delaying
important decisions until they had to be made, because
it would be too difficult to make them without context-
ual information:
P: I’d have to think about it at the time, because
that means I wouldn’t want someone to cure me of
pneumonia during a visit to A&E, if it’s just one of
a succession of weekly visits to A&E, no, I wouldn’t
want to be cured of pneumonia. But again, a
person’s wishes should be taken into account [PD
patient. P211].
P: No, I was asked about that [making advance care
decisions] and I didn’t want to do it. I really don’t
know how you can decide something like that [MS
patient. P411].
Mixed strategies
Participants did not always use a single coping strategy.
As their disease progressed, some moved between ‘tak-
ing each day as it comes’ and ‘advance planning’.
P: Well I did contact the MND Association up in
[Place], I said, “Look, send me your pack and I’ll
have a read,” and it was page after page, and as I
explained to a doctor at [Hospital], it can be quite
overwhelming, and he said, “Well that’s typical of
charitable organisations, that they sort of paint a
blacker picture, or tell you everything and you
have to stand back and say, well is that relevant
to me today, if that’s in the future we’ll worry
about it in the future,” and this is how I think my
wife and I have sort of come to terms with it, let’s
live a day at a time, and we’ll navigate through
sticky patches when we come to them [MND
patient. P314].
An added complexity was that patients and their carers
sometimes adopted different strategies:
P: I’ve started the Power of Attorney process but it’s
with my husband now to finish it off, he’s a little
bit of an ostrich, I think that’s fair to say [MND
patient. R313].
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P: Ah, me personally, yes, I would have done
[made advance care plans], if that had happened
to me I would have definitely chosen to do that, I
don’t think [Name] is the type of person that
would have done unfortunately [Carer of MS
patient. R423].
Some participants expressed regret that they had
not engaged with care planning earlier in the course
of their condition. For decisions concerning PEG
feeding, this lack of advance planning appeared to be
connected with a lack of information about the op-
tions. Two participants had PEGs fitted at a late, or
crisis stage, and both of their carers wished they had
made decisions earlier:
I: So do you wish you’d had yours [PEG tube] fitted a
bit earlier to stop those?
P: Yeah, it’s still a frightening thing but it could have
been done in an easier time for his/her body [Carer of
PSP patient. R521].
P: It was in the hospital, yeah, we made the
decision. S/he went in, s/he had an abscess on his/
her lung where s/he’d been swallowing food down
the wrong hole … well basically s/he nearly died
but the antibiotics kicked in and s/he was okay
and then we had the PEG fitted in there, we had
a lot of swallow tests and that done and then it
was decided that the only way really was a PEG….
If I’d have known and s/he would have known I
think we’d have had it a lot earlier [Carer of HD
patient. R622].
No decision to be made
For some participants the concept of care planning
did not make any sense, as they viewed the progres-
sion of their condition, and the need to accept in-
creasingly invasive treatment in order to stay alive, as
part of an inexorable process. Consequently, there
was no sense that they were choosing between plan-
ning in advance, or living in the present and delaying
making decisions about care until they could be put
off no longer. These participants described just doing
what it took to survive:
I: So is thickening your food and drink something that
you would consider, despite the horrible taste?
P: Well, I’ll do that when I’ve got no choice really.
I: And what about PEG feeding?
P: It might be the only way to feed me [MS patient.
P411].
Discussion
These results have clear implications for health pro-
fessionals attempting to deliver person-centred care
for people affected by progressive neurological condi-
tions. One of the most striking findings is the vari-
ation, between diagnostic groups, in the degree to
which participants appeared to be aware of what the
future may hold for them, and the treatment options
that may be available. It is unclear why those in the
Parkinson’s disease and dementia groups were, in
comparison with those affected by other conditions,
less able to describe their prognosis. It may be that
they had been provided with information but were
unable to recall it at the time of the interview, per-
haps as a result of cognitive impairment. However, it
is possible that health professionals had decided to
provide the most detailed information about progno-
sis, including the possibility of developing dysphagia,
to people with MND, PSP and CBD, as these are con-
ditions with a relatively rapid progression and a high
likelihood of developing dysphagia. Thus, patients
with these conditions may be seen as having a greater
need for information as they are more likely to be
faced with a need to make a decision about tube
feeding in the near future. In contrast, patients with
dementia and Parkinson’s disease, which have a slow
and uncertain trajectory, may be perceived as less
likely to have to make such a decision. The potential
risks of giving them information about treatment for
a distressing symptom that they may never develop
may therefore appear to outweigh the potential advantage
of enabling them to be involved in the decision to use
tube-feeding, should this decision need to be made in the
future after they have lost decision-making capacity. This
approach could be characterised as ‘physician-centred’:
the physician makes a decision about the patient’s infor-
mation needs, based on his or her expert knowledge of
the natural history of the patient’s condition and the likeli-
hood of particular treatments becoming appropriate in
the foreseeable future.
However, the findings of this study suggest that this
approach may not be the most effective way of meeting
the needs of individual patients. An understanding of their
attitude to advance care planning may provide a more
useful guide. The majority of participants were divided
into two groups: those who wanted to deal with healthcare
issues as they arose, live for the moment and not think
about the future; and those who asked questions of health-
care professionals, researched their condition on their own
and wanted to participate in shared decision-making and
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advance planning. Furthermore, the degree of health liter-
acy demonstrated in the interviews did not predict partici-
pants’ approach to care planning.
For both groups, their approach could be seen as a
mechanism for coping with the emotional burden and
magnitude of their diagnosis and its implications. Char-
maz has suggested that the suffering of chronic illness
involves the psychological suffering of the loss of self-
hood. She argues that, as disease progresses, individuals
may develop visible disabilities resulting in stigmatised
identities, or may suffer from discreditation of their
identity due to reduced participation in everyday life
[26]. Being unable to participate in mealtimes or having
visible problems with eating and drinking are such an
example. Participants choosing a strategy of ‘taking each
day as it comes’ can use this to resist stigmatisation, and
maintain their self-image as a ‘healthy person’ for as long
as possible. This avoids disrupting the narrative of their
life which could be psychologically destructive to their
sense of self, alongside the distress of the damage the ill-
ness is doing to their body. Conversely, engaging in active
planning and taking control of the situation, may help the
person to distance their own self-image, from the image of
‘a sick person’ who lacks autonomy and self-possession.
Charmaz argues that the self-discreditation of the chronic-
ally ill occurs when individuals can no longer take for
granted an attribute they view as fundamental. This could
include the power to make one’s own decisions.
The information needs of the two groups were not
straightforward. The group who preferred to ‘take each day
as it comes’ sometimes chose to do so because of the infor-
mation they had received regarding prognosis, and some
who had not made advance plans concerning the use of
PEG feeding came to regret not doing so. Conversely, not
everyone who engaged in advance planning wished to know
everything about the condition or its treatment, with some
expressing a wish for healthcare professionals to filter the
information provided, to avoid overwhelming them, and
others taking information provided by healthcare profes-
sionals into account but ultimately basing their decisions
on other factors. However, an understanding of the strategy
that each individual patient is adopting could usefully guide
healthcare professionals to engage in sensitive, nuanced
conversations that provide their patients with the informa-
tion that the need to know. Furthermore, the evidence that
people may switch between groups as the condition pro-
gresses suggests a need for healthcare professionals to re-
main alert to this possibility and adjust accordingly.
Potential limitations of the study
One limitation of the research design of this study is that
it may have over-represented participants who were
‘planners’, as only participants who were judged willing
to talk about the future were approached. Those who
wanted to not think about their condition could be un-
derrepresented: the population may include a larger
number of individuals who are less engaged with health-
care and prefer not to discuss about their condition.
Some participants suggested their approach to the
management of their own disease was a continuation of
their personality. However, these approaches may just
have been about the participants using the psychological
and emotional tools available to them at the time, and
not indicative of an underlying essential difference. In
fact, some participants used a mixed strategy approach
to their disease management, engaging at certain times
and selectively ignoring symptoms at others.
Conclusions
This longitudinal qualitative study of patients with pro-
gressive neurological disease and their families investi-
gated planning for the future and decision-making
concerning eating and drinking. The thematic analysis
revealed two key themes: 1) Health literacy: the extent
to which patients and carers appeared to know about
the condition and its treatment; and 2) Planning style:
the extent to which they appeared to value involvement
in advance care-planning.
Issues around eating and drinking are often over-
looked by doctors and seen as the remit of speech and
language therapists and nurses. However, the findings
from this study showed the key role of eating and drink-
ing in care-planning and the need for all clinicians to
understand both the patient’s level of health literacy and
their style of planning for the future before communicat-
ing about these sensitive issues.
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